Genix Pharmaceuticals (TSXV:GENX) Short-Term Capital Lease Obligation : C$0.00 Mil (As of Jan. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Short-Term Capital Lease Obligation?

Genix Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$0.00 Mil.

Genix Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Oct. 2022 (C$0.01 Mil) to Oct. 2023 (C$0.00 Mil) but then stayed the same from Oct. 2023 (C$0.00 Mil) to Oct. 2024 (C$0.00 Mil).

Genix Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Genix Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Short-Term Capital Lease Obligation Chart

Genix Pharmaceuticals Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.02

0.01

Genix Pharmaceuticals Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Genix Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Genix Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8

Website

https://www.genixpharm.com

Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.

Executives

Sina Pirooz	Director
Paul Chow	10% Security Holder, Director
Jamie A. Lewin	Director

Genix Pharmaceuticals Headlines

No Headlines